Published in
Springer Verlag, Journal of Neurology, 10(261), p. 2016-2018
DOI: 10.1007/s00415-014-7448-y
Links
Tools
First reported case of diabetes mellitus type 1 as a possible secondary autoimmune disease following alemtuzumab treatment in MS
This paper is available in a repository.
Full text: Download
Published version:
archiving forbidden
Data provided by 